Mission Pharmacal Drug Patent Portfolio
Mission Pharmacal owns 1 orange book drug protected by 1 US patent Given below is the list of Mission Pharmacal's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11458104 | Enteric coated tiopronin tablet | 14 Nov, 2038 | Active |
Latest Legal Activities on Mission Pharmacal's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mission Pharmacal.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Issue Date Used in PTA Calculation
Critical
| 04 Oct, 2022 | US11458104 |
|
Recordation of Patent Grant Mailed
Critical
| 04 Oct, 2022 | US11458104 |
|
Application ready for PDX access by participating foreign offices
Critical
| 04 Oct, 2022 | US11458104 |
|
Email Notification
Critical
| 15 Sep, 2022 | US11458104 |
|
Issue Notification Mailed
Critical
| 14 Sep, 2022 | US11458104 |
| Dispatch to FDC | 12 Sep, 2022 | US11458104 |
|
Application Is Considered Ready for Issue
Critical
| 12 Sep, 2022 | US11458104 |
|
Email Notification
Critical
| 05 Aug, 2022 | US11458104 |
| Mailing Corrected Notice of Allowability | 05 Aug, 2022 | US11458104 |
| Corrected Notice of Allowability | 01 Aug, 2022 | US11458104 |
|
Issue Fee Payment Received
Critical
| 26 Jul, 2022 | US11458104 |
|
Issue Fee Payment Verified
Critical
| 26 Jul, 2022 | US11458104 |
|
Pubs Case Remand to TC
Critical
| 19 Jul, 2022 | US11458104 |
|
Electronic Review
Critical
| 13 Jul, 2022 | US11458104 |
|
Email Notification
Critical
| 13 Jul, 2022 | US11458104 |
Mission Pharmacal's Drug Patent Litigations
Mission Pharmacal's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Oct 25, 2021, against patent number US11458104. The petitioner , challenged the validity of this patent, with Mission Pharmacal Company as the respondent. Click below to track the latest information on how companies are challenging Mission Pharmacal's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US11458104 | October, 2021 |
Decision
(15 Mar, 2022)
| Mission Pharmacal Company | |
Mission Pharmacal's Family Patents
Mission Pharmacal Drug List
Given below is the complete list of Mission Pharmacal's drugs and the patents protecting them.
1. Thiola Ec
Thiola Ec is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11458104 | Enteric coated tiopronin tablet |
14 Nov, 2038
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Thiola Ec's drug page